Atomo Diagnostics (AT1) Stock Price, News & Analysis

Company Overview

Atomo Diagnostics Limited engages in the development and sale of medical devices worldwide. It offers rapid diagnostic test devices for HIV screening, pregnancy test, and respiratory test. Atomo Diagnostics Limited was incorporated in 2010 and is headquartered in Leichhardt, Australia.

Key Stats

• Today's Range: N/A
• 50-Day Range: N/A
• 52-Week Range: N/A
• Volume: N/A
• Average Volume: N/A
• Market Capitalization: A$11.51 million
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: N/A

AT1 Stock Analysis - Frequently Asked Questions

What other stocks do shareholders of Atomo Diagnostics own?

Based on aggregate information from My MarketBeat watchlists, some other companies that Atomo Diagnostics investors own include Liontown Resources (LTR) and Black Cat Syndicate (BC8).

Industry, Sector and Symbol

• Stock Exchange: ASX
• Sector: Medical
• Industry: Medical Devices
• Sub-Industry: N/A
• Current Symbol: ASX:AT1
• CIK: N/A
• Web: atomodiagnostics.com
• Phone: 61 2 9099 4750
• Fax: N/A
• Employees: N/A
• Year Founded: N/A

Profitability

• EPS (Trailing Twelve Months): A($0.01)
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: -A$6.85 million
• Net Margins: -167.57%
• Pretax Margin: N/A
• Return on Equity: -57.57%
• Return on Assets: -29.88%

Debt

• Debt-to-Equity Ratio: 0.84
• Current Ratio: 6.39
• Quick Ratio: 10.22

Sales & Book Value

• Annual Sales: A$4.09 million
• Price / Sales: 0.00
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: A$0.02 per share
• Price / Book: N/A

Miscellaneous

• Outstanding Shares: 639,200,000
• Free Float: N/A
• Market Cap: A$11.51 million
• Optionable: Not Optionable
• Beta: 0.97